News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Daily News Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time Michael O'Riordan February 13, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Conference News ESC Heart Failure 2024 Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF Michael O'Riordan May 12, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Conference News ESC Heart Failure 2023 CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF Shelley Wood May 21, 2023
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022